Answers are grounded in this paper and cite their sources.
Review synthesizes findings on serotonin receptors in nicotine addiction, suggesting new therapeutic avenues.
Introduction: Nicotine dependence remains a global health burden with high relapse rates despite the availability of pharmacological aids. Emerging evidence implicates serotonin (5- HT) receptors in nicotine addiction and withdrawal. Methods: This review synthesizes preclinical and clinical findings on the roles of key 5-HT receptor subtypes-5-HT1A, 5-HT2A, 5-HT2C, 5-HT3, 5-HT4, and 5-HT6-in nicotine-related behaviors, with a focus on their therapeutic implications. Results: Current evidence suggests that specific 5-HT receptors contribute differentially to nicotine dependence and withdrawal. Selective Serotonin Reuptake Inhibitors (SSRIs) have shown limited clinical efficacy, while selective targeting of receptor subtypes, particularly 5-HT2C, demonstrates more consistent benefits in reducing nicotine-seeking and relapse. Discussion: Serotonergic mechanisms play a critical role in nicotine dependence. Targeted modulation of 5-HT receptor subtypes, especially 5-HT2C, may offer promising avenues for developing more effective smoking cessation therapies. Conclusion: Higher SUA/SCr levels were associated with better prognosis in females.
No takes yet. Share an insight, caveat, or question.
Tiwari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: